ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table 2 Characteristics Prediction Cohort Validation Cohort P value Number of patients
370 %
200 Age at diagnosis (y) 0.84 Median (mean) 55 54 Range 2 1 7 8 2 4 7 8 FIGO stage (2014) 0.52 IA 227 61.4 117 58.5 IB 52 14.1 24 12.0 II 36 9.7 20 10.0
III-IV 14.9 39 19.5" Grade (preoperative biopsy) / 1 311 84.4 2 18 4.4 3 27 7.4 Atypical hyperplasia 8 2.2$ Without preoperative biopsies 6 1.5 Grade (final pathology) 0.10 229 61.9 107 53.5 84 21.9 61 30.5 57 16.3 32 16.0 Myometrial invasion 0.86 < 1/2 262 69.7 143 71.5 ≥ 1/2 108 30.3 38.5 LVSI 0.61
Yes 75 19.6 37 22.0 No 295 80.4 163 78.0 Primary tumor diameter ≤ 2 cm 135 34.4 > 2 cm 235 65.6 Menopausal status 0.73 Pre-menopausal 148 38.1 77 Post-menopausal 222 123 61.5 Hypertension 100 26.7 47 23.5 0.36 Diabetes mellitus 23 6.3 16 8.0" Para-aortic node dissection 89 23.7 31 15.5 0.42 Node metastasis 10.7 26 13.0 0.38 Extent of lymphadenectomy 0.87 7 5 6 7 4 5
d MbP?_ % ' * + &P &F